Approval for the bayer immuno 1(tm) complexed psa assay.  The in vitro device is intended to quantitatively measure complexed prostate-specific antigen (cpsa) in human serum on the bayer immuno 1(tm) system.  This device is indicated for the measurement of serum complexed psa in conjunction with digital rectal exam (dre) as an aid in the detection of prostate cancer in men aged 50 years or older.  Biopsy of the prostate is required for the diagnosis of prostate cancer.  This device is further indicated as an aid in the management (monitoring) of prostate cancer patients.  This diagnostic method is not intended for use on any other system.